OptimizeRx (OPRX) vs Spok (SPOK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Spok (SPOK) has outperformed OptimizeRx (OPRX) over the past year, losing 30.4% versus a loss of 52.4%. Over five years, SPOK leads with a +11.5% price change compared with -89.9% for OPRX. Spok is the larger company by market cap ($231.1 million vs $161.0 million), about 1.4 times the size.
On valuation, OptimizeRx trades at a lower forward P/E (8.2x vs 13.2x for Spok). Spok pays a dividend yielding 11.31%, while OptimizeRx does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OPRX | SPOK |
|---|---|---|
| Share price | $8.55 | $11.05 |
| Market cap | $161.05M | $231.15M |
| 1-day change | -2.95% | +0.82% |
| YTD return | -30.26% | -16.22% |
| 1-year return | -52.37% | -30.37% |
| 5-year return | -89.90% | +11.50% |
| P/E ratio (TTM) | 35.63 | 19.39 |
| Forward P/E | 8.19 | 13.15 |
| EPS (TTM) | $0.24 | $0.57 |
| Dividend yield | 0.00% | 11.31% |
| Annual dividend | $0.00 | $1.25 |
| 52-week high | $22.25 | $16.45 |
| 52-week low | $4.54 | $9.95 |
| Distance from 52-week high | -61.57% | -32.83% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +47.37% | — |
| Average volume | 208.03K | 150.95K |
| Shares outstanding | 18.84M | 20.92M |
| Employees | 132 | 382 |
| Sector | Consumer Discretionary | Telecommunications |
| Industry | Business Services | Telecommunications Equipment |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SPOK has outperformed OPRX by 22.0 percentage points over the past year.
- OptimizeRx trades at a higher earnings multiple (35.6x vs 19.4x trailing P/E).
- Spok offers a meaningfully higher dividend yield (11.31% vs 0.00%).
- The two companies sit in different sectors: OptimizeRx in Consumer Discretionary and Spok in Telecommunications.
About OptimizeRx
OPRX stock →OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.
Consumer Discretionary · Business Services · 132 employees
About Spok
SPOK stock →Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance.
Telecommunications · Telecommunications Equipment · 382 employees
OPRX vs SPOK FAQ
Which is bigger, OptimizeRx or Spok?
Spok (SPOK) is larger, with a market capitalization of $231.15M compared with $161.05M for OptimizeRx (OPRX).
Which stock has performed better over the past year, OPRX or SPOK?
SPOK returned -30.37% over the past 12 months, compared with -52.37% for OPRX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, OPRX or SPOK?
SPOK has the lower trailing P/E at 19.4, versus 35.6 for OPRX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, OptimizeRx or Spok?
Spok pays a dividend yielding 11.31%, while OptimizeRx does not currently pay a regular dividend.
Are OptimizeRx and Spok in the same industry?
No. OptimizeRx is in the Consumer Discretionary sector, while Spok is in Telecommunications.